1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for CELU.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 2020. Start Trial.
Date Value
September 11, 2026 -39.48%
September 10, 2026 -38.94%
September 09, 2026 -36.28%
September 08, 2026 -27.01%
September 04, 2026 -28.81%
September 03, 2026 -28.24%
September 02, 2026 -27.06%
September 01, 2026 -52.28%
August 31, 2026 -53.05%
August 28, 2026 -58.96%
August 27, 2026 -44.74%
August 26, 2026 -77.60%
August 25, 2026 -79.15%
August 24, 2026 -79.56%
August 21, 2026 -77.84%
August 20, 2026 -78.99%
August 19, 2026 -78.45%
August 18, 2026 -82.25%
August 17, 2026 -80.00%
August 14, 2026 -79.89%
August 13, 2026 -80.47%
August 12, 2026 -77.45%
August 11, 2026 -78.32%
August 10, 2026 -78.81%
August 07, 2026 -78.44%
Date Value
August 06, 2026 -78.79%
August 05, 2026 -77.68%
August 04, 2026 -77.74%
August 03, 2026 -78.84%
July 31, 2026 -80.63%
July 30, 2026 -79.08%
July 29, 2026 -78.99%
July 28, 2026 -76.90%
July 27, 2026 -74.63%
July 24, 2026 -76.27%
July 23, 2026 -78.83%
July 22, 2026 -79.14%
July 21, 2026 -74.29%
July 20, 2026 -74.26%
July 17, 2026 -64.53%
July 16, 2026 -64.11%
July 15, 2026 -68.55%
July 14, 2026 -66.29%
July 13, 2026 -64.21%
July 10, 2026 -65.72%
July 09, 2026 -64.73%
July 08, 2026 -61.40%
July 07, 2026 -60.07%
July 06, 2026 -59.60%
July 02, 2026 -69.47%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
Tenax Therapeutics, Inc. -69.71%
Manhattan Scientifics, Inc. 9.90K%
Exicure, Inc. -61.11%
Century Therapeutics, Inc. 274.3%
Absci Corp. 199.6%